AI Signal & Stock Analysis · Avoid ↓
As of Aug 14 2026, 1:04 PM, AkshayaAI's signal for ARGX is Avoid ↓; the stock is at $847.64 (-1.09% today); neutral (RSI 45); technical trend is down-trend; news sentiment is positive.
Data as of Aug 14 2026, 1:04 PM. Informational analytics only — not investment advice.
| AI signal (Strength) | Avoid ↓ |
|---|---|
| Price | $847.64 |
| Change today | -1.09% |
| RSI (14) | 44.51 |
| Relative volume | 0.68 |
| Composite (RMTPGV) score | 🔒 members |
| Market cap | $53.0B |
| Forward P/E | 22.43 |
| 52-week high | -11.1% away |
| 52-week low | +31.6% above |
| Technical trend | Down-trend (since 2024-01-26) |
| News sentiment | Positive |
| Sector | Healthcare-Biotech |
| Next earnings | 7/23/2026 8:30:00 AM |
As of Aug 14 2026, 1:04 PM, AkshayaAI assigns ARGX (Argen X SE ADR) a Avoid signal. The composite (RMTPGV) score and full factor breakdown are available to signed-in members.
ARGX's RSI is neutral (RSI 45). A reading above 70 is typically considered overbought and below 30 oversold.
ARGX is trading about 11% below its 52-week high and 32% above its 52-week low as of Aug 14 2026, 1:04 PM.
ARGX's next earnings date is 7/23/2026 8:30:00 AM.
ARGX is classified under Healthcare-Biotech in AkshayaAI's taxonomy.
AkshayaAI provides AI-generated, informational stock analytics for US and India markets. This is not personalized investment advice. Figures are as of Aug 14 2026, 1:04 PM and may not reflect real-time prices. Always do your own research.
Instant, data-backed answers — free to try.